Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).
Abbott, Medtronic and Boston Scientific all ... both devices work via stimulation of the spinal cord. ARC-EX met its primary and secondary endpoints in a trial called Up-LIFT (NCT04697472) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback